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395Unraveling the Warp and Weft
of B Cell Fate
Two recent Immunity articles (Enzler et al., 2006; Sasa-
ki et al., 2006) probe the roles of Nuclear Factor k-B
(NF-kB) pathways in survival and differentiation medi-
ated by B cell activation factor of the TNF family
(BAFF).
The characterization of B cell activation factor of the
TNF family (BAFF, also termed BLyS) and its principal
receptor, BAFF-R, has provoked reassessment of the
notion that B cell receptor (BCR) signaling alone gov-
erns B cell survival and selection. Indeed, BAFF-R mu-
tations yield inordinate death among primary B cells de-
spite functional BCRs (Harless et al., 2001); and excess
BAFF fosters humoral autoimmunity in spite of normal
BCR diversity (Mackay et al., 1999). Nonetheless, the
BCR is equally critical to B cell survival (Lam et al.,
1997), and the outcome of BAFF signaling varies in the
context of both BAFF availability and BCR specificity
(Lesley et al., 2004; Thien et al., 2004). Thus, probing
BAFF signal transduction is a key first step towards re-
vealing why these two systems, while both necessary,
operate properly only in concert.
The nuclear factor-kB (NF-kB) family is an attractive
starting point for interrogation because its members
act downstream of several B cell surface molecules, in-
cluding CD40, Toll-like receptors (TLRs), and the BCR
(Figure 1). At least two pathways can initiate formation
of active NF-kB transcriptional regulators. The classical
(NF-kB1) pathway involves kinase cascades that de-
grade inhibitory complexes, affording nuclear localiza-
tion of active dimers; whereas the nonclassical (NF-
kB2) pathway regulates the formation of p52 via p100
degradation. Prior studies suggest that both pathways
are activated by BAFF (Hatada et al., 2003), and knock-
outs for either NF-kB essential modulator (NEMO) or for
NF-kB-inducing kinase (NIK)—upstream components
of NF-kB1 and NF-kB2 pathways, respectively—show
reduced B cell numbers reminiscent of BAFF-R defects.
Accordingly, two recent Immunity articles (Enzler et al.,
2006; Sasaki et al., 2006) have employed powerful gene-knockout and transgenic strategies to probe the role of
each NF-kB pathway in BAFF-mediated survival and
selection.
Citing the similarities between NEMO- and BAFF-R-
deficient phenotypes, Sasaki et al. reason that enforced
NF-kB1 activity should circumvent BAFF-R defects and
restore B cell survival. They test this idea by character-
izing mice in which a constitutively active IkB Kinase 2
(IKK2ca) is expressed in mice lacking BAFF-R. These
mice exhibit B cell subset distributions similar to those
of BAFF-R-sufficient controls, and their B cells display
characteristics associated with BAFF-R function, such
as nuclear exclusion of protein kinase-Cd (PKC-d) and
upregulation of Bcl-2 family members including Bcl-xl
and A1. Nonetheless, several observations hint at addi-
tional requirements for optimal BAFF signaling. First, as
the authors note, NEMO deficiency yields a milder B cell
phenotype than does BAFF-R deficiency. Second,
IKK2ca expression in BAFF-R-sufficient mice yields
about twice as many B cells as it does in the BAFF-R
knockouts, suggesting BAFF-R per se provides addi-
tional, non-redundant signals. Finally, BCR signaling re-
mains necessary for fully appropriate responses to this
arm of the BAFF-R cascade; IKK2ca fails to rescue mar-
ginal-zone development in mice lacking the BCR core-
ceptor component CD19.
Enzler et al. not only examine survival but also exploit
the emergence of autoreactivity as a measure of
BAFF-R activity in vivo. Consistent with Sasaki et al.,
they find that BAFF-R activates the NF-kB1 pathway
and influences BAFF-mediated survival in vitro. How-
ever, they find that NF-kB2 is necessary for optimal sur-
vival, as well as for maximal upregulation of Bcl-2 gene
family members. Moreover, they observe a strict NF-
kB2 requirement for induction of the pro-survival kinase
Pim-2 and resultant Bad phosphorylation. Thus, al-
though NF-kB1 is clearly important for BAFF-R signal-
ing, NF-kB2 seems necessary for full function. Extend-
ing the suggestion of such complementary roles to an
in vivo system, they assess how blocking each pathway
impacts marginal-zone differentiation and autoantibody
formation in BAFF transgenics. They find that BAFF sig-
naling through NF-kB2 upregulates integrins and leads
to marginal-zone retention and survival of autoreactive
B cells; their findings extend earlier reports that showed
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in excess BAFF and that their admission to the marginal
zone is critically dependent on BAFF availability (Lesley
et al., 2004; Thien et al., 2004). Although not required for
these effects, NF-kB1 seems necessary for the appear-
ance of isotype-switched serum autoantibodies.
This emerging picture suggests that a model of sym-
biotic crosstalk between the two NF-kB pathways and
their upstream activators may reconcile otherwise per-
plexing disparities. For example, Sasaki et al. show that
constitutive NF-kB1 activation yields increased p100
and thus provides a key substrate for the NF-kB2 path-
way. However, in the absence of BAFF-R, p52 genera-
tion is curtailed despite these elevated p100 levels.
Thus, the synergistic effects reported by Enzler et al.,
as well as the additional effectiveness of BAFF-R when
it is present with IKK2ca, might reflect a role for NF-kB1-
dependent p100 generation in sustaining BAFF-R-
driven NF-kB2 activation. Extending this notion of cross-
talk to other B cell surface molecules that stimulate
NF-kB pathways has potentially exciting ramifications.
Figure 1. BAFF Acts through Both NF-kB1 and NF-kB2 Pathways to
Foster Survival and Differentiation
Both classical and nonclassical NF-kB pathways are activated by
BAFF/BAFF-R interactions, leading to the upregulation of gene
products key to survival, differentiation, and localization. Although
some of these actions seem to be limited to either NF-kB1 or NF-
kB2, others appear to be under synergistic control. These pathways
also lie downstream from BCR signaling, which along with BAFF is
essential for B cell survival, as well as downstream from several
other B cell ligand-receptor systems. Together, this growing list sug-
gests a general model whereby exogenous cues are integrated to
yield apposite survival and differentiation responses.It may disclose how BCR signaling through NF-kB1
can govern NF-kB2-dependent aspects of BAFF-R
function; for example, such aspects might include pos-
itive selection and marginal-zone differentiation. In-
deed, BCR signaling strength governs both of these
events, but the thresholds vary with BAFF availability.
Similarly, such crosstalk may begin to explain how
CD40 costimulation, which strongly activates both NF-
kB pathways, can alone mediate survival and differenti-
ation, whereas innate activation receptors that sidestep
costimulation yield a different and more limited subset
of these outcomes. Probing the exact nature of this
crosstalk will require interrogating the upstream molec-
ular connections between these pathways and key B
cell activation and regulatory receptors, as well as de-
termining how the balance of these signals impacts
the mix of downstream transcriptional regulators.
Thus, these papers together set the stage for unravel-
ing the molecular weaving of B cell fate by suggesting
mutually supporting roles for NF-kB1 and NF-kB2 path-
ways in BAFF signaling (Figure 1). Understanding this
relationship should prove key to revealing how BAFF
regulates B cell survival and differentiation in a con-
text-dependent manner. It likely includes semiautono-
mous roles for each pathway, such that signals diverge
downstream of BAFF-R to regulate survival and differ-
entiation. In addition, it provides a fabric within which
signals from BAFF-R, the BCR, and other receptors up-
stream of NF-kB pathways can interweave and thus
allow survival and differentiation to be guided by the
aggregate of these inputs.
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